Parenting — Parental Support Intervention in the Oncological Context
Citation(s)
Cessna JM, Pidala J, Jacobsen PB Relationships between parenting self-efficacy and distress in parents who have school-aged children and have been treated with hematopoietic stem cell transplant or have no cancer history. Psychooncology. 2016 Mar;25(3):3
Ellis SJ, Wakefield CE, Antill G, Burns M, Patterson P Supporting children facing a parent's cancer diagnosis: a systematic review of children's psychosocial needs and existing interventions. Eur J Cancer Care (Engl). 2017 Jan;26(1). doi: 10.1111/ecc.124
Inhestern L, Haller AC, Wlodarczyk O, Bergelt C Psychosocial Interventions for Families with Parental Cancer and Barriers and Facilitators to Implementation and Use - A Systematic Review. PLoS One. 2016 Jun 8;11(6):e0156967. doi: 10.1371/journal.pone.015
Koopman HM, Baars RM, Chaplin J, Zwinderman KH Illness through the eyes of the child: the development of children's understanding of the causes of illness. Patient Educ Couns. 2004 Dec;55(3):363-70.
Kuhl PK Early language acquisition: cracking the speech code. Nat Rev Neurosci. 2004 Nov;5(11):831-43. Review.
Rauch PK, Muriel AC The importance of parenting concerns among patients with cancer. Crit Rev Oncol Hematol. 2004 Jan;49(1):37-42. Review.
Semple CJ, McCaughan E Family life when a parent is diagnosed with cancer: impact of a psychosocial intervention for young children. Eur J Cancer Care (Engl). 2013 Mar;22(2):219-31. doi: 10.1111/ecc.12018. Epub 2012 Dec 12.
Syse A, Aas GB, Loge JH Children and young adults with parents with cancer: a population-based study. Clin Epidemiol. 2012;4:41-52. doi: 10.2147/CLEP.S28984. Epub 2012 Mar 13.
Children Facing Parental Cancer : a Randomized Controlled Study Evaluating the Efficacy of a Psychological Intervention to Support Parenting
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
